China Pharma Holdings reported that its second-quarter net income was $5.1 million, or $0.12 per share, down from $6.1 million, or $0.14 per share, in the second quarter of 2010. Excluding the effect of change in fair value of derivative warrant liability, adjusted non-GAAP net income in the second quarter of 2011 was $4.8 million, or $0.11 per share, compared to $5.3 million, or $0.12 per share, in the second quarter of 2010.
Honeywell will acquire Johnson Matthey's Catalyst Technologies business segment for €2.15 billion in an all-cash transaction.
The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.
Oxea is returning to its old name and its roots.
This interview covers key results of the study ‘Success Factor Supply Chain Management and Logistics in the Chemical Industry 2024’ by Solventure, Aimms and Miebach.
Novo Nordisk recently announced changes to its executive leadership and Board of Directors.
